Skip to content

INOVIO PHARMACEUTICALS, INC.: filings

Every INOVIO PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-12fiscal Q2 2026351010001055726-26-000023
10-Q2026-05-13fiscal Q1 202635730001055726-26-000018
10-K2026-03-12fiscal FY 202543880001055726-26-000008
10-Q2025-11-10fiscal Q3 2025391150001055726-25-000063
10-Q2025-08-12fiscal Q2 2025391110001055726-25-000055
10-Q2025-05-13fiscal Q1 202539810001055726-25-000026
10-K2025-03-18fiscal FY 202446940001055726-25-000012
10-Q2024-11-14fiscal Q3 2024401170001055726-24-000052
10-Q2024-08-08fiscal Q2 2024391110001055726-24-000046
10-Q2024-05-13fiscal Q1 202440840001055726-24-000020
10-K2024-03-06fiscal FY 2023491270001055726-24-000011
10-Q2023-11-09fiscal Q3 2023421190001055726-23-000055
10-Q2023-08-09fiscal Q2 2023421150001055726-23-000051
10-Q2023-05-10fiscal Q1 202343890001055726-23-000030
10-K2023-03-01fiscal FY 2022531350001055726-23-000010
10-Q2022-11-08fiscal Q3 2022451270001055726-22-000055
10-Q2022-08-09fiscal Q2 2022451230001055726-22-000049
10-Q2022-05-10fiscal Q1 202245930001055726-22-000034
10-K2022-03-01fiscal FY 2021531350001055726-22-000008
10-Q2021-11-09fiscal Q3 2021481370001055726-21-000062
10-Q2021-08-09fiscal Q2 2021481330001055726-21-000055
10-Q2021-05-10fiscal Q1 202144910001055726-21-000040
10-K2021-03-01fiscal FY 2020532290001055726-21-000018
10-Q2020-11-09fiscal Q3 2020491410001055726-20-000052
10-Q2020-08-10fiscal Q2 2020451210001055726-20-000048
10-Q2020-05-11fiscal Q1 202046950001055726-20-000032
10-K2020-03-12fiscal FY 2019562360001055726-20-000012
10-Q2019-11-12fiscal Q3 2019511470001055726-19-000058
10-Q2019-08-08fiscal Q2 2019511430001055726-19-000052
10-Q2019-05-09fiscal Q1 201946950001055726-19-000029
10-K2019-03-12fiscal FY 2018502030001055726-19-000012
10-Q2018-11-08fiscal Q3 2018461270001055726-18-000045
10-Q2018-08-07fiscal Q2 2018451250001055726-18-000040
10-Q2018-05-09fiscal Q1 201843900001055726-18-000026
10-K2018-03-14fiscal FY 2017491920001055726-18-000014
10-Q2017-11-08fiscal Q3 2017421140001055726-17-000039
10-Q2017-08-08fiscal Q2 201736930001055726-17-000036
10-Q2017-05-10fiscal Q1 201740810001055726-17-000024
10-K2017-03-15fiscal FY 2016482020001055726-17-000013
10-Q2016-11-09fiscal Q3 2016431200001055726-16-000067
10-Q2016-08-08fiscal Q2 2016411130001055726-16-000062
10-Q2016-05-09fiscal Q1 201640820001055726-16-000040
10-K2016-03-14fiscal FY 2015482220001055726-16-000033
10-Q2015-11-09fiscal Q3 2015431200001055726-15-000015
10-Q2015-08-10fiscal Q2 2015411120001055726-15-000010
10-Q2015-05-11fiscal Q1 201541840001055726-15-000007
10-K2015-03-16fiscal FY 2014472110001055726-15-000003
10-Q2014-11-10fiscal Q3 2014411120001055726-14-000013
10-Q2014-08-11fiscal Q2 2014411120001055726-14-000010
10-Q2014-05-12fiscal Q1 201436740001055726-14-000006
10-K2014-03-17fiscal FY 2013421640001055726-14-000003
10-Q2013-11-12fiscal Q3 201336920001055726-13-000011
10-Q2013-08-09fiscal Q2 201336920001055726-13-000008
10-Q2013-05-10fiscal Q1 201336740001055726-13-000005
10-K2013-03-18fiscal FY 2012421640001445305-13-000665
10-Q2012-11-07fiscal Q3 201235920001193125-12-457586
10-Q2012-08-09fiscal Q2 201235900001193125-12-347489
10-Q2012-05-09fiscal Q1 201234680001193125-12-222402
10-K2012-03-15fiscal FY 201135910001193125-12-117292
10-Q2011-11-07fiscal Q3 201134860001193125-11-298587
10-Q2011-08-05fiscal Q2 201134850001193125-11-212333

Inspect the source

Entity
INOVIO PHARMACEUTICALS, INC. / CIK 0001055726
Captured
2026-09-20T05:17:43.559Z
SEC response SHA-256
9bfa830827e08b2d190e6d0b4ce0274a3c0d8852b6e536b16b5cfeadcaa54cf9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001055726.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))